KEGG MEDICUS Search Result |
Top |
| Entry | Name | Name(TN) | Disease |
|---|---|---|---|
| D10545 | Batefenterol (USAN) | ||
| D10546 | Batefenterol succinate (USAN) | ||
| D10547 | Brincidofovir (USAN) | Tembexa (TN) | Human smallpox disease [DS:H00372] |
| D10548 | Cabotegravir (JAN/USAN/INN) |
Vocabria (TN) Apretude (TN) |
|
| D10549 | Cabotegravir sodium (JAN/USAN) | Vocabria (TN) | HIV-1 infection [DS:H01563] |
| D10550 |
Censavudine (USAN) Festinavir |
||
| D10551 | Ceritinib (JAN/USAN/INN) | Zykadia (TN) | Non-small cell lung cancer (ALK positive) [DS:H00014] |
| D10552 | Dactolisib (USAN/INN) | ||
| D10553 | Dasabuvir (USAN/INN) | ||
| D10554 | Deleobuvir (USAN/INN) | ||
| D10555 | Duvelisib (USAN/INN) | ||
| D10556 | Fimasartan (INN) | ||
| D10557 |
Evolocumab (USAN/INN) Evolocumab (genetical recombination) (JAN) |
Repatha (TN) |
Primary hyperlipidemia [DS:H01635] Homozygous familial hypercholesterolemia [DS:H00155] Heterozygous familial hypercholesterolemia [DS:H00155] |
| D10558 | Umifenovir (INN) | ||
| D10559 |
Dinutuximab (USAN/INN) Dinutuximab (genetical recombination) (JAN) |
Unituxin (TN) | Neuroblastoma [DS:H02301] |
| D10560 | Idelalisib (JAN/USAN/INN) | Zydelig (TN) | Chronic lymphocytic leukemia [DS:H00005] |
| D10561 | Fabomotizole (INN) | ||
| D10562 | Macimorelin acetate (USAN) | Macrilen (TN) | |
| D10563 | Macimorelin (USAN) | ||
| D10564 | Amenamevir (JAN/INN) | Amenalief (TN) | |
| D10565 | Pefcalcitol (JAN/USAN/INN) | ||
| D10566 | Pasireotide pamoate (JAN) | Signifor lar (TN) |
Acromegaly [DS:H01483] Cushing’s disease [DS:H01431] |
| D10567 |
Fasiglifam hydrate (JAN) Fasiglifam hemihydrate |
||
| D10568 | Pitavastatin calcium hydrate (JP18) | Livalo (TN) | |
| D10569 | Tafluprost and timolol maleate | Tapcom (TN) | |
| D10570 | Insulin degludec (genetical recombination) and insulin aspart (genetical recombination) | Ryzodeg (TN) | |
| D10571 | Rilpivirine hydrochloride, tenofovir disoproxil fumarate and emtricitabine |
Complera (TN) Eviplera (TN) |
HIV-1 infection [DS:H01563] |
| D10572 |
Fosnetupitant and palonosetron hydrochloride Netupitant and palonosetron hydrochloride |
Akynzeo (TN) | |
| D10573 | Sodium hyaluronate crosslinked polymer (JAN) | Synvisc (TN) | |
| D10574 |
Pembrolizumab (USAN) Pembrolizumab (genetical recombination) (JAN) |
Keytruda (TN) |
Melanoma [DS:H00038] Non-small cell lung cancer (PD-L1 expressed) [DS:H00014] Head and neck squamous cell carcinoma (PD-L1 expressed) [DS:H02420] Head and neck squamous cell carcinoma [DS:H02420] Hodgkin lymphoma [DS:H00007] Mediastinal large B-cell lymphoma [DS:H02434] Urothelial carcinoma [DS:H00022] Solid tumor (MSI-H or dMMR) [DS:H02421] Colorectal cancer (MSI-H) [DS:H00020] Gastric cancer (HER2 positive) [DS:H00018] Esophageal cancer (PD-L1 expressed) [DS:H00017] Cervical cancer (PD-L1 expressed) [DS:H00030] Hepatocellular carcinoma [DS:H00048] Merkel cell carcinoma [DS:H01555] Renal cell carcinoma [DS:H00021] Endometrial carcinoma (MSI-H or dMMR) [DS:H00026] Solid tumor (TMB-H) [DS:H02421] Cutaneous squamous cell carcinoma [DS:H00040] Breast cancer (triple-negative, PD-L1 expressed) [DS:H00031] |
| D10575 | Finafloxacin (INN) | Xtoro (TN) | |
| D10576 | Ombitasvir (USAN/INN) | ||
| D10577 |
Ceftolozane sulfate and tazobactam sodium (abbr) C/T |
Zerbaxa (TN) | |
| D10578 | Ledipasvir and sofosbuvir | Harvoni (TN) | Chronic hepatitis C virus infection [DS:H00413] |
| D10579 |
Conjugated estrogens and bazedoxifene acetate Oestrogens conjugated with bazedoxifene acetate |
Duavee (TN) Duavive (TN) |
Osteoporosis [DS:H01593] |
| D10580 | Paritaprevir (USAN/INN) | ||
| D10581 |
Dasabuvir sodium hydrate Dasabuvir sodium monohydrate |
Exviera (TN) | |
| D10582 | Dasabuvir, ombitasvir, paritaprevir and ritonavir | Viekira pak (TN) | Chronic hepatitis C virus infection [DS:H00413] |
| D10583 | Aftobetin (USAN/INN) | ||
| D10584 | Buparlisib (USAN/INN) |
| [ KEGG | NETWORK | DISEASE | DRUG | MEDICUS ] |